DelveInsight’s, “Mesothelioma Pipeline Insight 2025” report provides comprehensive insights about 45+ companies and 50+ ...
Mestag Therapeutics ("Mestag"), a biotech company harnessing fibroblast immunology for the benefit of patients with inflammatory disease and ...
Earlier in his career, whilst Dr. Sleeman was the Cambridge site lead for the Respiratory, Inflammation and Autoimmunity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback